STOCK OPTIONS (Details - Stock options granted) - USD ($) |
3 Months Ended | 12 Months Ended | ||||||
|---|---|---|---|---|---|---|---|---|
Jul. 31, 2026 |
Apr. 30, 2026 |
Jan. 31, 2026 |
Jul. 31, 2025 |
Apr. 30, 2025 |
Jan. 31, 2025 |
Oct. 31, 2025 |
Oct. 31, 2024 |
|
| Share-Based Payment Arrangement [Abstract] | ||||||||
| Number of shares at beginning balance | 339,673 | 350,194 | 350,194 | 284,461 | 284,461 | 284,461 | 284,461 | |
| Weighted average exercise price at beginning balance | $ 2.20 | $ 2.15 | $ 2.15 | $ 0.45 | $ 0.45 | $ 0.45 | $ 0.45 | |
| Weighted average remaining contractual term | 5 years 11 months 23 days | 6 years 2 months 23 days | 6 years 5 months 23 days | 6 years 3 months 7 days | 6 years 6 months 7 days | 6 years 9 months 7 days | 6 years 8 months 23 days | 7 years 7 days |
| Aggregate intrinsic value at beginning balance | $ 3,298,610 | $ 1,618,854 | $ 438,197 | $ 6,980,951 | $ 6,980,951 | $ 6,980,951 | $ 6,980,951 | |
| Number of shares issued | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Weighted average exercise price issued | $ 0 | $ 0 | $ 0 | $ 0 | $ 0 | $ 0 | ||
| Aggregate intrinsic value issued | $ 0 | $ 0 | $ 0 | $ 0 | $ 0 | $ 0 | ||
| Number of shares canceled | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Weighted average exercise price canceled | $ 0 | $ 0 | $ 0 | $ 0 | $ 0 | $ 0 | ||
| Aggregate intrinsic value canceled | $ 0 | $ 0 | $ 0 | $ 0 | $ 0 | $ 0 | ||
| Number of shares exercised | 10,521 | 0 | 0 | 0 | 0 | |||
| Weighted average exercise price exercised | $ 0 | $ 0.45 | $ 0 | $ 0 | $ 0 | $ 0 | ||
| Aggregate intrinsic value exercised | $ 0 | $ 0 | $ 0 | $ 0 | $ 0 | $ 0 | ||
| Number of shares at ending balance | 339,673 | 339,673 | 350,194 | 284,461 | 284,461 | 284,461 | 350,194 | 284,461 |
| Weighted average exercise price at ending balance | $ 2.20 | $ 2.20 | $ 2.15 | $ 0.45 | $ 0.45 | $ 0.45 | $ 2.15 | $ 0.45 |
| Aggregate intrinsic value at ending balance | $ 3,038,367 | $ 3,298,610 | $ 1,618,854 | $ 6,980,951 | $ 6,980,951 | $ 6,980,951 | $ 438,197 | $ 6,980,951 |
| Number of shares Exercisable | 329,740 | |||||||
| Number of shares Exercisable per shares | $ 2.20 | |||||||
| Weighted average remaining contractual term Exercisable | 5 years 11 months 8 days | |||||||
| Aggregate intrinsic value Exercisable | $ 3,047,342 | |||||||
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Gross number of share options (or share units) granted during the period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of options outstanding, including both vested and non-vested options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average price at which option holders acquired shares when converting their stock options into shares. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted-average contractual term remaining for vested portion of option outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted-average contractual term remaining for option award outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of share options (or share units) exercised during the current period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|